AMC075: A sequential phase I/randomized phase II trial of vorinostat and risk-adapted chemotherapy with rituximab in HIV-related B-cell non-Hodgkin’s lymphoma

Journal article

Peer reviewed

J. C Ramos, J. A Sparano, P. C Moore, R. F Ambinder, A Noy, R. T Mitsuyasu and AIDS Malignancy Consortium

Journal of clinical oncology, Vol.29(15_suppl), pp.e13002-e13002

2011-05-20

Metrics

4 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: AMC075: A sequential phase I/randomized phase II trial of vorinostat and risk-adapted chemotherapy with rituximab in HIV-related B-cell non-Hodgkin’s lymphoma
Creators: J. C Ramos
J. A Sparano
P. C Moore
R. F Ambinder
A Noy
R. T Mitsuyasu
AIDS Malignancy Consortium
Publication Details: Journal of clinical oncology, Vol.29(15_suppl), pp.e13002-e13002
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600043002976